This website is intended for healthcare professionals only.

Newsletter          
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Cardiovascular

Phase IIIa clinical trial data presented for oral semaglutide
Phase IIIa clinical trial data presented for oral semaglutide
Weekly pharmacy visits boost drug adherence and quality of life in heart failure patients
Weekly pharmacy visits boost drug adherence and quality of life in heart failure patients
Expert consensus published on use of imaging to guide heart attack treatment
Expert consensus published on use of imaging to guide heart attack treatment
Protecting against heart disease in lupus and beyond
Protecting against heart disease in lupus and beyond
First study in PAH using cardiac MRI as a primary endpoint presented
First study in PAH using cardiac MRI as a primary endpoint presented
How could high intensity interval training affect cardiovascular conditions?
How could high intensity interval training affect cardiovascular conditions?
New scientific statement on blood pressure measurement published
New scientific statement on blood pressure measurement published
Three in 10 drug-related deaths in acute care due to omitted medicines, research reveals
Three in 10 drug-related deaths in acute care due to omitted medicines, research reveals
Snoring poses a greater cardiac risk to women
Snoring poses a greater cardiac risk to women
Diabetes prescriptions cost NHS over £1bn a year, data reveals
Diabetes prescriptions cost NHS over £1bn a year, data reveals
Sponsored – The importance of vascular access device selection: case study
Implanted cardiac defibrillator (ICD) can put a stop to underlying cardiac arrhythmia
Implanted cardiac defibrillator (ICD) can put a stop to underlying cardiac arrhythmia


Popular articles

Pholcodine containing cough and cold medicines withdrawn from UK market
Ketogenic diet linked to higher LDL cholesterol and increased risk of adverse cardiac events
DNA damage to oral cells similar in never smoking vapers and current smokers
Oral PCSK9 inhibitor significantly lowers LDL cholesterol in adults with hypercholesterolaemia
Both controlled and uncontrolled hypertension in obese patients increase all-cause mortality risk




 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora